What one share of Praxis Precision Medicines holds
We are a fully integrated, leading central nervous system, or CNS, precision neuroscience biopharmaceutical company translating insights from genetic epilepsies into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance.
Praxis Precision Medicines’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$12.87 |
|---|---|
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$11.59 |
| Cash and investments | $49.21 |
| Book value | $48.04 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | — | −$398.94 | $1.01 | −$328.74 | — | −$749.20 |
| 2020 | — | −$117.86 | $0.00 | −$88.19 | — | — |
| 2021 | — | −$59.03 | $0.37 | −$44.38 | — | $83.05 |
| 2022 | $0.00 | −$69.65 | $0.14 | −$60.36 | — | $23.12 |
| 2023 | $0.37 | −$18.69 | $0.01 | −$16.86 | — | $7.92 |
| 2024 | $0.48 | −$10.21 | $0.00 | −$7.36 | — | $22.93 |
| 2025 | $0.00 | −$13.48 | $0.00 | −$11.07 | — | $34.85 |
Common questions about Praxis Precision Medicines
How much does one share of Praxis Precision Medicines earn?
Over the last 12 months, Praxis Precision Medicines lost $12.87 for each share.
Does Praxis Precision Medicines pay a dividend?
Praxis Precision Medicines didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Praxis Precision Medicines’s book value per share?
Praxis Precision Medicines’s book value is $48.04 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Praxis Precision Medicines have?
Each share of Praxis Precision Medicines has $49.21 of cash and investments, as of June 30, 2026.
What is Praxis Precision Medicines’s free cash flow per share?
−$11.59 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Praxis Precision Medicines bought back shares?
Praxis Precision Medicines’s share count rose about 21969% from 2019 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.